When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FDA OKs Seattle Genetics ADC for urothelial cancer; shares up 6% after hours
Astellas Pharma Inc
Under accelerated review status, the FDA approves Seattle Genetics (NASDAQ:SGEN) and collaboration partners Astellas Pharma's (OTCPK:ALPMF) antibody-drug conjugate (ADC) Padcev (enfortumab vedotin-ejfv) for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/L1 inhibitor and platinum-containing chemo before (neoadjuvant) or after (adjuvant) surgery.
More news on: Seattle Genetics, Inc., Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news, Stocks on the move,